• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 MAGIC3 GO¿ INTERMITTENT URINARY CATHETER; INTERMITTENT CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 MAGIC3 GO¿ INTERMITTENT URINARY CATHETER; INTERMITTENT CATHETER Back to Search Results
Catalog Number 51812
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Urinary Tract Infection (2120)
Date of Event 08/15/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that patient who was disabled had been using bd brand of catheters for more than 5 years.It was reported in late april 2023, that the manufacturer bard was halting production due to material shortages and production issues and asked to temporarily use a different manufactures product.However, they still had ample supply of the magic3 go intermittent silicone catheter and continued to use the overflow of catheters.On 01aug2023, they received via email a recall notice from supplier.They would like to know how long bard knew about the possible contamination and when the suppliers of recalled product (magic3 go intermittent silicone catheter) were notified.Also stated that 50 boxes of product were contaminated.As per follow up via phone on 10aug2023, there was no allegation against the device.The customer was wanting information on the recall.As per follow up information received on (b)(6) 2023, customer experienced urinary tract infection over the last year or more.Three lot numbers were provided (jugt0319 ), (jugp2374), (jufy9030).
 
Additional Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that patient who was disabled had been using bd brand of catheters for more than 5 years.It was reported in late (b)(6) 2023, that the manufacturer bard was halting production due to material shortages and production issues and asked to temporarily use a different manufactures product.However, they still had ample supply of the magic3 go intermittent silicone catheter and continued to use the overflow of catheters.On (b)(6) 2023, they received via email a recall notice from supplier.They would like to know how long bard knew about the possible contamination and when the suppliers of recalled product (magic3 go intermittent silicone catheter) were notified.Also stated that 50 boxes of product were contaminated.As per follow up via phone on (b)(6)2023, there was no allegation against the device.The customer was wanting information on the recall.As per follow up information received on (b)(6) 2023, customer experienced urinary tract infection over the last year or more.Three lot numbers were provided (jugt0319), (jugp2374), (jufy9030).
 
Additional Manufacturer Narrative
The reported event was inconclusive because no sample was returned.A potential root cause for this failure could be "patient sensitivity to materials".It was unknown whether the device had met relevant specifications.A review of the device history record did not show any problems or conditions that would have contributed to the reported issue.The instructions for use were found adequate and states the following: ¿indications for use the magic3 go¿ intermittent urinary catheter is intended for urological use only.It is intended for use by adult female patients for bladder management including urine drainage, collection, and measurement.The device is passed to the urinary bladder via the urethra.Contraindications none known warnings this is a single use device.Do not resterilize any portion of this device.Reuse and/or repackaging may create a risk of patient or user infection, compromise the structural integrity and/or essential material and design characteristics of the device, which may lead to device failure, and/or lead to injury, illness or death of the patient.Precautions inspect the catheter before use.Do not use the product if the device or packaging is damaged.Adverse reactions urinary tract infection bleeding from the urethra irritation of the urethra review the self-catheterization procedure with a healthcare professional.1.Always wash hands prior to use.2.Open the catheter package by peeling the tab upwards with the aid of the finger hole.3.If desired, hang the package with the adhesive surface on the inner side of the tab to a nearby dry vertical surface while preparing to catheterize.4.Positioned comfortably with thighs spread apart, clean the opening to the urethra ¿ and the surrounding area.Wipe from front to back to avoid fecal contamination.Wash your hands again.5.Remove the catheter with the aid of the insertion handle and advance the catheter tip into the urethra.Slowly and gently insert the catheter into the urethra until urine begins to flow (approximately 1-1.5" or 2.5-3.8 cm).6.When urine stops flowing, begin to withdraw the catheter.It is recommended to slowly rotate the catheter during withdrawal, stopping each time urine begins to flow.Check the color, odor and clarity of the urine.Any changes may need to be reported to a health care professional.Disposal 7.Place the catheter back into the package and dispose in accordance with accepted medical practice and applicable local, state and federal laws and regulations.Do not flush down the toilet.8.Wash hands.¿ correction- h h11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : the device was not returned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MAGIC3 GO¿ INTERMITTENT URINARY CATHETER
Common Device Name
INTERMITTENT CATHETER
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer (Section G)
C.R. BARD INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer Contact
xeeroy rada
8195 industrial blvd
covington 30014
7707846100
MDR Report Key17611432
Report Number1018233-2023-06273
Device Sequence Number7552145
Product Code EZD
UDI-Device Identifier00801741097874
UDI-Public(01)00801741097874
Combination Product (Y/N)N
Initial Reporter StateNJ
Initial Reporter CountryUS
PMA/510(K) Number
K150345
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Consumer
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 09/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date02/28/2025
Device Catalogue Number51812
Device Lot NumberJUGP2374
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/15/2023
Supplement Date Received by Manufacturer09/12/2023
Initial Report FDA Received Date08/24/2023
Supplement Report FDA Received Date09/13/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured03/13/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-